1. Pharmaprojects New Developments
Wendy Manning
Deputy Editor, Pharmaprojects

2. What’s New? Pharmaprojects v 5.1 launched Aug 2004
Subsequent enhancements
Launch of v5.2 planned for Aug 2006
and finally.. Pharmapredict

3. Pharmaprojects v5.1 Protein target data
Searchable Lipinski “Rule of 5” parameters
Enhanced detailed information searching

4. Subsequent Enhancements
New Stem Cell Classification added
More timely updates
12 years of Trends data ( )

5. Upcoming for v5.2 Data enhancements
Enhanced classification of Licensing Opportunities
NCE Flag
Target Families

6. Target Family Groupings
ENZYMES - subclasses and EC numbers
RECEPTORS - subclasses (2 levels)
HORMONES
CYTOKINES - subclasses
TRANSPORTERS - subclasses and TC numbers

7. Upcoming for v5.2 www.pharmaprojects.com Improving Usability
“Quick Search” function
Simplified general method of searching
More logical navigation to Graphs and reports
Links to PubMed abstracts

8. Pharmapredict Forecasting/Benchmarking tool
Browser-based web application
Pharmaprojects list price subscribers receive preferential rate

9. Pharmapredict-analyses
Estimate time to market/launch date
Look at “launch landscape”
Chance of success/attrition rates
Estimated sales data from Evaluate Pharma